Boris A. Hadaschik, MD, is Director and Chair of the Department of Urology, Essen University Hospital, University of Duisburg-Essen, Essen, Germany. He attained his medical degree in 2002 at the University of Heidelberg, School of Medicine, Germany. This was in parallel with obtaining a Master of Music degree from the University of Music, Karlsruhe, Germany, in 1998. In 2003, he began his residency in Heidelberg and Mainz, Germany. In 2006, he was awarded a 2-year postdoctoral research fellowship from the German Research Association at the Vancouver Prostate Centre in Vancouver, BC, Canada. Following that, he completed his residency at the University of Heidelberg and became board-certified in urology in 2009. In 2010 and 2012, he became board-certified in medical tumour therapy and andrology, respectively.
Professor Hadaschik’s main research interests lie in the development of prostate cancer diagnostics (such as image-guided biopsy) and therapy (including molecularly targeted radiopharmaceuticals) to improve and individualise cancer care and patient outcomes. He is the co-founder of the Ginsburg Study Group for Enhanced Prostate Diagnostics and a member of several international working groups attempting to optimise magnetic resonance imaging-targeted prostate biopsy. In addition, he is a principal investigator of the German multicentre PROBASE trial for prospective randomised evaluation of risk-adapted prostate-specific antigen screening in 50,000 young men.
Professor Hadaschik has won numerous awards including the German Urological Association’s highest scientific award, the Maximilian Nitze Prize. He has authored more than 200 peer-reviewed articles and currently has an h-index of 36.
Preparation date: January 2019 - Zinc code: PHEM/ONCS/1018/0002f